The seed round was backed by British Design Fund to support the development of novel wound care devices.
Corryn Biotechnologies
Corryn Biotechnologies develops novel wound dressing technology for the treatment of chronic and complex wounds.
£550KTotal raised
Corryn Biotechnologies is a medical device startup developing regenerative wound dressings to improve healing outcomes. The company is based in South Wales.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Corryn Biotechnologies's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders

Luke Burke
Co-founder & CEO
Luke is the co-founder and chief executive officer of Corryn Biotechnologies. He previously held research and development roles at Medtronic, Aditlys Medical, Xeltis, and Avectas.
LinkedInInvestors
Funding history
£550K